IPSC
Price
$0.54
Change
-$0.03 (-5.26%)
Updated
Jun 27 closing price
Capitalization
46.09M
39 days until earnings call
KRON
Price
$0.88
Change
+$0.01 (+1.15%)
Updated
Jun 20 closing price
Capitalization
53.65M
39 days until earnings call
Interact to see
Advertisement

IPSC vs KRON

Header iconIPSC vs KRON Comparison
Open Charts IPSC vs KRONBanner chart's image
Century Therapeutics
Price$0.54
Change-$0.03 (-5.26%)
Volume$6.19M
Capitalization46.09M
Kronos Bio
Price$0.88
Change+$0.01 (+1.15%)
Volume$54.09K
Capitalization53.65M
IPSC vs KRON Comparison Chart in %
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. KRON commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and KRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (IPSC: $0.54 vs. KRON: $0.88)
Brand notoriety: IPSC and KRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 666% vs. KRON: 5%
Market capitalization -- IPSC: $46.09M vs. KRON: $53.65M
IPSC [@Biotechnology] is valued at $46.09M. KRON’s [@Biotechnology] market capitalization is $53.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileKRON’s FA Score has 1 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • KRON’s FA Score: 1 green, 4 red.
According to our system of comparison, KRON is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 4 TA indicator(s) are bullish while KRON’s TA Score has 6 bullish TA indicator(s).

  • IPSC’s TA Score: 4 bullish, 5 bearish.
  • KRON’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KRON is a better buy in the short-term than IPSC.

Price Growth

IPSC (@Biotechnology) experienced а -8.06% price change this week, while KRON (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IPSC is expected to report earnings on Aug 07, 2025.

KRON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRON($53.7M) has a higher market cap than IPSC($46.1M). KRON YTD gains are higher at: -7.368 vs. IPSC (-47.030). IPSC has higher annual earnings (EBITDA): -5.99M vs. KRON (-49.14M). IPSC has more cash in the bank: 165M vs. KRON (99.7M). KRON has less debt than IPSC: KRON (24.1M) vs IPSC (52.7M). IPSC has higher revenues than KRON: IPSC (115M) vs KRON (9.19M).
IPSCKRONIPSC / KRON
Capitalization46.1M53.7M86%
EBITDA-5.99M-49.14M12%
Gain YTD-47.030-7.368638%
P/E RatioN/AN/A-
Revenue115M9.19M1,251%
Total Cash165M99.7M165%
Total Debt52.7M24.1M219%
TECHNICAL ANALYSIS
Technical Analysis
IPSCKRON
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPGNF1.45N/A
N/A
Grupo Gigante S.A.B. de C.V.
NEWEN96.03N/A
N/A
New England Power Co.
DECXF0.02N/A
N/A
Decade Resources Ltd.
GRRLF0.12N/A
N/A
Grange Resources Ltd.
TDHOY10.50-0.15
-1.41%
T&D Holdings, Inc.

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-5.74%
CRSP - IPSC
57%
Loosely correlated
N/A
CRBU - IPSC
53%
Loosely correlated
-5.19%
KYTX - IPSC
52%
Loosely correlated
-5.48%
IMNM - IPSC
52%
Loosely correlated
-0.23%
NTLA - IPSC
51%
Loosely correlated
-0.52%
More

KRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRON has been loosely correlated with VSTM. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if KRON jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRON
1D Price
Change %
KRON100%
N/A
VSTM - KRON
33%
Loosely correlated
-0.24%
TNXP - KRON
31%
Poorly correlated
-1.83%
SNSE - KRON
29%
Poorly correlated
+3.58%
OCGN - KRON
28%
Poorly correlated
-4.46%
IPSC - KRON
28%
Poorly correlated
-5.74%
More